Articles

Financing is returning to commercial real estate ahead of 2025, yet mostly on temporary terms.

BofA sees the stock “priced to perfection,” while noting lesser visibility into tech deals and renewed attention on fair-value accounting.

AppLovin’s $135 billion market cap and 900% year-to-date surge through Friday’s close weren’t enough to earn it entry into the benchmark large-cap index.

BP has agreed to spin off its its offshore-wind into a newly formed joint venture with Japan’s JERA.

Super Micro’s stock rallies after Nasdaq extends the deadline for financial filings, but the stock is still being weighed down by an accounting overhang.

AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug Administration in 2025.

A pair of big-money acquisitions by advertising company Omnicom and insurance broker Arthur J. Gallagher tip the scales at a combined $27 billion.

A BofA analyst downgraded AMD’s stock, warning of limitations on the company’s ability to pick up share in an AI market dominated by Nvidia.

The social-media platform is expanding its beta test of Reddit Answers, the company said Monday.

Oppenheimer Asset Management’s chief investment strategist, John Stoltzfus, predicts the S&P 500 will reach 7,100 in 2025, thanks in part to a resilient economy.

Barclays upgrades Robinhood and Schwab to overweight from equal-weight as analyst sees “constructive” trading backdrop in 2025.

Some investing pros study the past. Others look ahead. Why it’s important to do both.